AOBiome
MA - CambridgeBiotechnology
Focus: AOBiome is a Cambridge-based biotech pioneer in bacterial skin therapy, focusing on immunology, dermatology, neurology, and cardiovascular applications. The company is in early-to-mid clinical development stage with a focused pipeline of novel topical and systemic bacterial therapeutics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About AOBiome
AI assessmentNot HiringNo open roles listed right now. Follow AOBiome to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AO+Mist
Keratosis PilarisClinical Trials (2)
NCT03243617Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis Pilaris
N/AHelp build intelligence for AOBiome
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.